TRxADE HEALTH Statistics
Total Valuation
TRxADE HEALTH has a market cap or net worth of $8.21 million. The enterprise value is $13.87 million.
| Market Cap | 8.21M |
| Enterprise Value | 13.87M |
Important Dates
The next estimated earnings date is Tuesday, May 28, 2024, after market close.
| Earnings Date | May 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TRxADE HEALTH has 1.41 million shares outstanding. The number of shares has increased by 320.30% in one year.
| Shares Outstanding | 1.41M |
| Shares Change (YoY) | +320.30% |
| Shares Change (QoQ) | +11.09% |
| Owned by Insiders (%) | 24.06% |
| Owned by Institutions (%) | 9.49% |
| Float | 720,008 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.83 |
| PS Ratio | 0.99 |
| Forward PS | 0.87 |
| PB Ratio | 15.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.24, with a Debt / Equity ratio of 13.10.
| Current Ratio | 0.24 |
| Quick Ratio | 0.23 |
| Debt / Equity | 13.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.89 |
Financial Efficiency
Return on equity (ROE) is -622.70% and return on invested capital (ROIC) is -94.99%.
| Return on Equity (ROE) | -622.70% |
| Return on Assets (ROA) | -170.10% |
| Return on Capital (ROIC) | -94.99% |
| Revenue Per Employee | $1.03M |
| Profits Per Employee | -$2.23M |
| Employee Count | 8 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 170.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.98% in the last 52 weeks. The beta is 2.04, so TRxADE HEALTH's price volatility has been higher than the market average.
| Beta (1Y) | 2.04 |
| 52-Week Price Change | +17.98% |
| 50-Day Moving Average | 11.36 |
| 200-Day Moving Average | 7.80 |
| Relative Strength Index (RSI) | 38.20 |
| Average Volume (30 Days) | 430,669 |
Short Selling Information
The latest short interest is 12,167, so 0.87% of the outstanding shares have been sold short.
| Short Interest | 12,167 |
| Short Previous Month | 20,528 |
| Short % of Shares Out | 0.87% |
| Short % of Float | 1.69% |
| Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, TRxADE HEALTH had revenue of $8.27 million and -$17.84 million in losses. Loss per share was -$7.49.
| Revenue | 8.27M |
| Gross Profit | 2.60M |
| Operating Income | -7.26M |
| Pretax Income | -17.84M |
| Net Income | -17.84M |
| EBITDA | -15.60M |
| EBIT | -16.65M |
| Loss Per Share | -$7.49 |
Balance Sheet
The company has $1.45 million in cash and $7.10 million in debt, giving a net cash position of -$5.65 million or -$4.02 per share.
| Cash & Cash Equivalents | 1.45M |
| Total Debt | 7.10M |
| Net Cash | -5.65M |
| Net Cash Per Share | -$4.02 |
| Equity / Book Value | 542,353 |
| Book Value Per Share | 0.39 |
| Working Capital | -8.80M |
Cash Flow
| Operating Cash Flow | -2.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.07M |
| FCF Per Share | -$2.71 |
Margins
Gross margin is 31.41%, with operating and profit margins of -87.80% and -215.70%.
| Gross Margin | 31.41% |
| Operating Margin | -87.80% |
| Pretax Margin | -215.70% |
| Profit Margin | -215.70% |
| EBITDA Margin | -188.53% |
| EBIT Margin | -201.22% |
| FCF Margin | -25.07% |
Dividends & Yields
TRxADE HEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -320.30% |
| Shareholder Yield | -320.30% |
| Earnings Yield | -217.26% |
| FCF Yield | -25.25% |
Analyst Forecast
The average price target for TRxADE HEALTH is $18.75, which is 221.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.75 |
| Price Target Difference | 221.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 22, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
TRxADE HEALTH has an Altman Z-Score of -7.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.87 |
| Piotroski F-Score | 2 |